| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-- | -- | -- | 0 | 0 |
|
Research and Development Expenses
|
-13,467 | -10,279 | -5,229 | -8,113 | -12,955 |
| Other Income/Expense, Operating
|
-9,853 | -10,853 | -10,565 | -9,871 | -1,631 |
|
Operating Income/Expenses
|
-23,320 | -21,132 | -15,794 | -17,984 | -14,586 |
|
Total Operating Profit/Loss
|
-23,320 | -21,132 | -15,794 | -17,984 | -14,586 |
| Total Net Finance Income/Expense
|
-4 | 1 | 808 | 1,144 | -6 |
| Net Investment Income
|
-1,534 | 2,700 | -1,760 | -402 | -869 |
| Irregular Income/Expenses
|
-- | -- | -- | -- | 0 |
|
Other Income/Expense, Non-Operating
|
521 | -- | 0 | 0 | 65 |
|
Non-Operating Income/Expenses, Total
|
-1,866 | 2,701 | -952 | 742 | -810 |
|
Pretax Income
|
-25,186 | -18,431 | -16,746 | -17,242 | -15,397 |
|
Provision for Income Tax
|
0 | 0 | 4,883 | -449 | 0 |
|
Net Income from Continuing Operations
|
-25,186 | -18,431 | -11,863 | -17,691 | -15,397 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-25,186 | -18,431 | -11,863 | -17,691 | -15,397 |
|
Net Income after Non-Controlling/Minority Interests
|
-25,186 | -18,431 | -11,863 | -17,691 | -15,397 |
|
Net Income Available to Common Stockholders
|
-25,186 | -18,431 | -11,863 | -17,691 | -15,397 |
|
Diluted Net Income Available to Common Stockholders
|
-25,186 | -18,431 | -11,863 | -17,691 | -15,397 |
| Basic EPS
|
-0.21 | -0.16 | -0.11 | -0.17 | -0.15 |
| Diluted EPS
|
-0.21 | -0.16 | -0.11 | -0.17 | -0.15 |
|
Basic Weighted Average Shares Outstanding
|
123,806.4760 | 118,282.7530 | 106,672.3420 | 102,471.0160 | 101,526.3890 |
|
Diluted Weighted Average Shares Outstanding
|
123,806.4760 | 118,282.7530 | 106,672.3420 | 102,471.0160 | 101,526.3890 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-25,182 | -18,432 | -17,554 | -18,386 | -15,391 |
|
EBITDA
|
-24,878 | -18,198 | -17,430 | -18,290 | -15,340 |
|
Normalized EBITDA
|
-22,258 | -19,909 | -14,082 | -14,635 | -18,935 |
|
Normalized Income
|
-22,566 | -20,142 | -9,491.2500 | -14,036 | -18,992 |
|
Total Unusual Items
|
2,620 | -1,711 | 3,348 | 3,655 | -3,595 |
|
Total Unusual Items Excluding Goodwill
|
2,620 | -1,711 | 3,348 | 3,655 | -3,595 |
|
Tax Effect of Unusual Items
|
0 | 0 | 976.2500 | 0 | 0 |
12/31/2022 - 11/20/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade